Radient Pharmaceuticals Corporation
(Other OTC/NBB : RXPC)

( )
RXPC PreMarket: $ () as of AM
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield

Message Boards



Health Technology » Medical Specialties

Company Profile

Radient Pharmaceuticals Corp. engages in the research, development, manufacturing, sale and marketing of its Onko-Sure test kit, a proprietary in-vitro diagnostic cancer test. It enables physicians and their patients to detect and monitor the treatment of solid tumors by measuring the accumulation of blood. Onko-Sure is a simple, non-invasive blood test designed to be used for the detection and/or monitoring of cancers, including lung, breast, tongue, stomach, liver, colon, rectal, bladder, brain, hematological, prostate, ovarian, esophageal, cervical, uterine, liver, trophoblastic, thyroid, malignant lymphoma, and pancreatic cancers. The company was founded in 1987 and is headquartered in Tustin, CA.